SKI 1695Alternative Names: NSC D665585
Latest Information Update: 04 Jun 1998
At a glance
- Originator SK Pharma
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 04 Jun 1998 Discontinued-Preclinical for HIV-1 infections in South Korea (Unknown route)
- 05 Jan 1995 Preclinical development for HIV-1 infections in South Korea (Unknown route)